GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Resverlogix Corp (FRA:RFS) » Definitions » Short Percentage of Float

Resverlogix (FRA:RFS) Short Percentage of Float


View and export this data going back to 2005. Start your Free Trial

What is Resverlogix Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Resverlogix's Short Percentage of Float

For the Biotechnology subindustry, Resverlogix's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Resverlogix's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Resverlogix's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Resverlogix's Short Percentage of Float falls into.


Resverlogix (FRA:RFS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Resverlogix Corp (FRA:RFS) » Definitions » Short Percentage of Float
Comparable Companies
TSXV:KNE TSXV:SBM TSX:ATE TSXV:CYTO XCNQ:MDMA XCNQ:TELI XCNQ:PREV TSX:AEZS TSXV:CZO TSXV:XRTX OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
RVXCF:USA RFS:Germany RVX:Canada
Address
4820 Richard Road South West, Suite 300, Calgary, AB, CAN, T3E 6L1
Website
https://www.resverlogix.com
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.

Resverlogix (FRA:RFS) Headlines

No Headlines